Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Johnson & Johnson

JNJ Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$JNJ stock is featured in our Rob Bresnahan, Shelley Moore Capito, and Tina Smith strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of JNJ by members of U.S. Congress

Politician Type Traded
Thomas H. Kean, Jr. House / R Sale $1,001 - $15,000 Aug 27, 2026
John Boozman Senate / R Sale (Partial) $1,001 - $15,000 Aug 20, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Aug 07, 2026
Richard McCormick House / R Sale $1,001 - $15,000 Jul 30, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 20, 2026
Thomas H. Kean, Jr. House / R Sale $1,001 - $15,000 Jun 29, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 16, 2026
Lloyd Doggett House / D Purchase $1,001 - $15,000 Jun 09, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 02, 2026
Thomas H. Kean, Jr. House / R Sale $1,001 - $15,000 Jun 02, 2026
Ro Khanna House / D Sale $15,001 - $50,000 May 15, 2026
Ro Khanna House / D Sale $1,001 - $15,000 May 01, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 Apr 13, 2026
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 30, 2026
Alan Armstrong Senate / R Purchase $15,001 - $50,000 Mar 27, 2026
Thomas H. Kean, Jr. House / R Sale $1,001 - $15,000 Mar 26, 2026
John Boozman Senate / R Sale (Partial) $1,001 - $15,000 Mar 19, 2026
Richard McCormick House / R Sale $1,001 - $15,000 Mar 19, 2026
Richard McCormick House / R Sale $1,001 - $15,000 Mar 19, 2026
Lloyd Doggett House / D Purchase $1,001 - $15,000 Mar 10, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 06, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 05, 2026
Thomas H. Kean, Jr. House / R Sale $15,001 - $50,000 Jan 23, 2026
Julie Johnson House / D Sale $1,001 - $15,000 Dec 18, 2025
Lloyd Doggett House / D Purchase $1,001 - $15,000 Dec 09, 2025
Thomas H. Kean, Jr. House / R Sale $15,001 - $50,000 Nov 20, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Nov 13, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 Nov 07, 2025
Richard McCormick House / R Purchase $1,001 - $15,000 Nov 05, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 30, 2025
Jared Moskowitz House / D Sale $1,001 - $15,000 Oct 10, 2025
Jared Moskowitz House / D Sale $1,001 - $15,000 Oct 10, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2025
Val T. Hoyle House / D Sale $1,001 - $15,000 Sep 23, 2025
Kelly Morrison House / D Sale $1,001 - $15,000 Aug 19, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Aug 14, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Aug 04, 2025
Thomas H. Kean, Jr. House / R Sale $15,001 - $50,000 Jul 31, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 Jul 25, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 Jul 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jul 01, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jul 01, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Jun 24, 2025
JNJ Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
JNJ Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
JNJ Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in JNJ holdings by institutional investors

Quarterly net insider trading by JNJ's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $1,440,000 Jul 20, 2026 Issue: Defense Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)
  • $3,510,000 Apr 20, 2026 Issue: Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)
  • $1,510,000 Jan 20, 2026 Issue: Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)
  • $2,480,000 Oct 20, 2025 Issue: Taxation/Internal Revenue Code Veterans Trade (domestic/foreign) Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology
  • $1,030,000 Jul 21, 2025 Issue: Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans
  • $3,340,000 Apr 21, 2025 Issue: Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice
  • $1,520,000 Jan 21, 2025 Issue: Budget/Appropriations Health Issues Labor Issues/Antitrust/Workplace Veterans Consumer Issues/Safety/Products Science/Technology Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Environment/Superfund Bankruptcy Medicare/Medicaid Law Enforcement/Crime/Criminal Justice
  • $2,340,000 Oct 21, 2024 Issue: Law Enforcement/Crime/Criminal Justice Medicare/Medicaid Bankruptcy Environment/Superfund Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Science/Technology Consumer Issues/Safety/Products Trade (domestic/foreign) Veterans Labor Issues/Antitrust/Workplace Health Issues Budget/Appropriations
  • $1,120,000 Jul 22, 2024 Issue: Law Enforcement/Crime/Criminal Justice Medicare/Medicaid Bankruptcy Environment/Superfund Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Science/Technology Consumer Issues/Safety/Products Trade (domestic/foreign) Veterans Labor Issues/Antitrust/Workplace Health Issues Budget/Appropriations
  • $1,160,000 Jan 22, 2024 Issue: Medicare/Medicaid Bankruptcy Environment/Superfund Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Science/Technology Consumer Issues/Safety/Products Trade (domestic/foreign) Veterans Labor Issues/Antitrust/Workplace Health Issues Budget/Appropriations
  • $2,350,000 Oct 20, 2023 Issue: Medicare/Medicaid Bankruptcy Environment/Superfund Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Science/Technology Consumer Issues/Safety/Products Trade (domestic/foreign) Veterans Labor Issues/Antitrust/Workplace Health Issues Budget/Appropriations
  • $850,000 Jul 20, 2023 Issue: Bankruptcy Environment/Superfund Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Science/Technology Consumer Issues/Safety/Products Trade (domestic/foreign) Veterans Labor Issues/Antitrust/Workplace Health Issues Budget/Appropriations Medicare/Medicaid
  • $2,270,000 Jan 20, 2023 Issue: Bankruptcy Civil Rights/Civil Liberties Science/Technology Trade (domestic/foreign) Taxation/Internal Revenue Code Environment/Superfund Consumer Issues/Safety/Products Budget/Appropriations Health Issues
  • $2,170,000 Oct 20, 2022 Issue: Bankruptcy Civil Rights/Civil Liberties Science/Technology Trade (domestic/foreign) Taxation/Internal Revenue Code Environment/Superfund Consumer Issues/Safety/Products Budget/Appropriations Health Issues
  • $1,050,000 Jul 20, 2022 Issue: Bankruptcy Civil Rights/Civil Liberties Science/Technology Trade (domestic/foreign) Taxation/Internal Revenue Code Environment/Superfund Consumer Issues/Safety/Products Budget/Appropriations Health Issues
  • $2,320,000 Apr 20, 2022 Issue: Bankruptcy Civil Rights/Civil Liberties Science/Technology Trade (domestic/foreign) Taxation/Internal Revenue Code Environment/Superfund Consumer Issues/Safety/Products Budget/Appropriations Health Issues
  • $880,000 Jan 20, 2022 Issue: None
  • $1,920,000 Oct 20, 2021 Issue: None
  • $800,000 Jul 20, 2021 Issue: None
  • $2,480,000 Apr 20, 2021 Issue: None
  • $1,450,000 Jan 21, 2021 Issue: None
  • $860,000 Oct 20, 2020 Issue: None
  • $1,760,000 Jul 20, 2020 Issue: None
  • $1,480,000 Apr 20, 2020 Issue: None
  • $1,350,000 Jan 21, 2020 Issue: None
  • $810,000 Oct 21, 2019 Issue: Science/Technology Torts Labor Issues/Antitrust/Workplace Budget/Appropriations Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Environment/Superfund
  • $2,150,000 Jul 22, 2019 Issue: Science/Technology Torts Labor Issues/Antitrust/Workplace Environment/Superfund Budget/Appropriations Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans Medicare/Medicaid Health Issues
  • $1,440,000 Apr 22, 2019 Issue: Torts Environment/Superfund Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,340,000 Jan 22, 2019 Issue: Labor Issues/Antitrust/Workplace Budget/Appropriations Veterans Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Torts
  • $1,980,000 Oct 22, 2018 Issue: Immigration Budget/Appropriations Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Labor Issues/Antitrust/Workplace Torts
  • $870,000 Jul 20, 2018 Issue: Torts Labor Issues/Antitrust/Workplace Immigration Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans
  • $1,370,000 Apr 20, 2018 Issue: Torts Labor Issues/Antitrust/Workplace Budget/Appropriations Medicare/Medicaid Veterans Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $3,650,000 Jan 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Torts
  • $810,000 Oct 20, 2017 Issue: Torts Budget/Appropriations Veterans Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $1,290,000 Jul 20, 2017 Issue: Budget/Appropriations Veterans Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Environment/Superfund
  • $1,060,000 Apr 20, 2017 Issue: Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,460,000 Jan 23, 2017 Issue: Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Animals
  • $890,000 Oct 20, 2016 Issue: Animals Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,040,000 Jul 20, 2016 Issue: Animals Environment/Superfund Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $1,140,000 Apr 20, 2016 Issue: Animals Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,210,000 Jan 20, 2016 Issue: Insurance Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Animals
  • $780,000 Oct 20, 2015 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Environment/Superfund Insurance
  • $2,420,000 Jul 20, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Insurance Animals Environment/Superfund
  • $1,820,000 Apr 20, 2015 Issue: Animals Insurance Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Environment/Superfund
  • $1,400,000 Jan 20, 2015 Issue: Consumer Issues/Safety/Products Environment/Superfund Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign) Budget/Appropriations
  • $1,350,000 Oct 20, 2014 Issue: Environment/Superfund Medicare/Medicaid Health Issues Copyright/Patent/Trademark Financial Institutions/Investments/Securities Manufacturing Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products Taxation/Internal Revenue Code
  • $1,060,000 Jul 21, 2014 Issue: Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Manufacturing Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $2,110,000 Apr 21, 2014 Issue: Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Manufacturing Trade (domestic/foreign) Financial Institutions/Investments/Securities Taxation/Internal Revenue Code
  • $860,000 Jan 21, 2014 Issue: Consumer Issues/Safety/Products Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign) Environment/Superfund Medicare/Medicaid
  • $1,280,000 Oct 21, 2013 Issue: Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign)
  • $2,070,000 Jul 22, 2013 Issue: Law Enforcement/Crime/Criminal Justice Consumer Issues/Safety/Products Environment/Superfund Medicare/Medicaid Health Issues Trade (domestic/foreign) Budget/Appropriations Financial Institutions/Investments/Securities Taxation/Internal Revenue Code
  • $1,360,000 Jul 22, 2013 Issue: Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign)
  • $880,000 Jan 22, 2013 Issue: Environment/Superfund Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign) Budget/Appropriations Torts Consumer Issues/Safety/Products Law Enforcement/Crime/Criminal Justice
  • $1,420,000 Oct 22, 2012 Issue: Law Enforcement/Crime/Criminal Justice Torts Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign)
  • $1,200,000 Jul 20, 2012 Issue: Law Enforcement/Crime/Criminal Justice Torts Environment/Superfund Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products
  • $2,260,000 Apr 20, 2012 Issue: Law Enforcement/Crime/Criminal Justice Torts Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Trade (domestic/foreign)
  • $930,000 Jan 20, 2012 Issue: Law Enforcement/Crime/Criminal Justice Torts Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Financial Institutions/Investments/Securities
  • $1,440,000 Dec 15, 2011 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Government Issues Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $1,770,000 Oct 20, 2011 Issue: Torts Consumer Issues/Safety/Products Environment/Superfund Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Law Enforcement/Crime/Criminal Justice Copyright/Patent/Trademark Budget/Appropriations
  • $1,300,000 Jul 20, 2011 Issue: Torts Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Environment/Superfund Law Enforcement/Crime/Criminal Justice
  • $1,710,000 Apr 19, 2011 Issue: Law Enforcement/Crime/Criminal Justice Torts Consumer Issues/Safety/Products Environment/Superfund Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $2,410,000 Oct 20, 2010 Issue: Torts Consumer Issues/Safety/Products Medicare/Medicaid Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Environment/Superfund Medical/Disease Research/Clinical Labs
  • $1,150,000 Jul 20, 2010 Issue: Torts Consumer Issues/Safety/Products Medicare/Medicaid Copyright/Patent/Trademark Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Health Issues Environment/Superfund Medical/Disease Research/Clinical Labs
  • $1,440,000 Jun 18, 2010 Issue: Medical/Disease Research/Clinical Labs Pharmacy Government Issues Consumer Issues/Safety/Products Environment/Superfund Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Defense Budget/Appropriations Law Enforcement/Crime/Criminal Justice
  • $2,110,000 Apr 20, 2010 Issue: Torts Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Environment/Superfund Medical/Disease Research/Clinical Labs
  • $1,660,000 Oct 20, 2009 Issue: Medical/Disease Research/Clinical Labs Environment/Superfund Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities Copyright/Patent/Trademark Budget/Appropriations Consumer Issues/Safety/Products Torts
  • $1,555,000 Jul 20, 2009 Issue: Medical/Disease Research/Clinical Labs Environment/Superfund Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products
  • $1,530,000 Apr 20, 2009 Issue: Budget/Appropriations Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Environment/Superfund Consumer Issues/Safety/Products Medical/Disease Research/Clinical Labs
  • $1,440,000 Jan 19, 2009 Issue: Medical/Disease Research/Clinical Labs Pharmacy Government Issues Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Environment/Superfund Law Enforcement/Crime/Criminal Justice
  • $1,500,000 Oct 20, 2008 Issue: Medical/Disease Research/Clinical Labs Pharmacy Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Defense Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Government Issues
  • $1,700,000 Jul 17, 2008 Issue: Pharmacy Consumer Issues/Safety/Products Environment/Superfund Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Defense Budget/Appropriations Government Issues Medical/Disease Research/Clinical Labs Law Enforcement/Crime/Criminal Justice
  • $1,440,000 Apr 21, 2008 Issue: Law Enforcement/Crime/Criminal Justice Medical/Disease Research/Clinical Labs Pharmacy Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Defense
  • $3,880,000 Feb 14, 2008 Issue: Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Defense Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Law Enforcement/Crime/Criminal Justice
  • $3,820,000 Aug 14, 2007 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Defense Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations Pharmacy Medical/Disease Research/Clinical Labs Law Enforcement/Crime/Criminal Justice
  • $2,080,000 Feb 14, 2007 Issue: Torts Pharmacy Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
  • $3,300,000 Aug 14, 2006 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Torts Budget/Appropriations Health Issues Medicare/Medicaid Pharmacy
  • $3,360,000 Feb 14, 2006 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Torts
  • $2,020,000 Aug 12, 2005 Issue: Torts Pharmacy Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
  • $2,380,000 Aug 12, 2005 Issue: None
  • $2,340,000 Aug 16, 2004 Issue: Torts Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Taxation/Internal Revenue Code
  • $2,140,000 Feb 17, 2004 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations Torts
  • $2,200,000 Aug 14, 2003 Issue: Trade (domestic/foreign) Budget/Appropriations Torts Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid
  • $2,100,000 Feb 21, 2003 Issue: Torts Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,660,000 Sep 03, 2002 Issue: None
  • $1,620,000 Feb 14, 2002 Issue: Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Torts
  • $1,620,000 Aug 14, 2001 Issue: Torts Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,620,000 Feb 15, 2001 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Aviation/Airlines/Airports Torts
  • $1,160,000 Aug 14, 2000 Issue: Torts Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $760,000 Feb 14, 2000 Issue: Torts Trade (domestic/foreign) Aviation/Airlines/Airports Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
  • $800,000 Aug 16, 1999 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Budget/Appropriations Trade (domestic/foreign)

Former government officials who have lobbied for JNJ

113 former government officials from 71 congressional offices at 24 lobbying firms have lobbied for JNJ, most recently Aug 14, 2026.

  • Lucy McBath
    Michael Williams House New Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019) Formerly with Lucy McBath · FORBES-TATE · Aug 14, 2026
  • Ron Kind
    Cynthia Brown House New Chief of Staff, Rep. Ron Kind (2003-2009) Formerly with Ron Kind · FORBES-TATE · Aug 14, 2026
  • Allen Boyd
    Elizabeth Greer House New Chief of Staff, Rep. Allen Boyd (2001-2009) Formerly with Allen Boyd · FORBES-TATE · Aug 14, 2026
  • Brett Guthrie
    Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 21, 2026
  • Brett Guthrie
    Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 21, 2026
  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Jul 21, 2026
  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Ad · TODD STRATEGY GROUP · Jul 21, 2026
  • Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee Formerly Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legis · TODD STRATEGY GROUP · Jul 21, 2026
See all 113 on the Revolving Door dashboard

JNJ Estimated quarterly lobbying spending

JNJ Revenue by Segment or Geography

By Segment
By Geography
JNJ Income Statement
JNJ Balance Sheet
JNJ Cash Flow
U.S. Patents

New JNJ patent grants

  • Patent Title: Tampon press Mar. 25, 2025
  • Patent Title: Apparatus for forming a catamenial tampon Mar. 25, 2025
  • Patent Title: Shaped tampon Aug. 13, 2024
  • Patent Title: Tampon press Apr. 09, 2024
  • Patent Title: Apparatus for forming a catamenial tampon Mar. 05, 2024
  • Patent Title: Method of forming primary package tube for tampons Dec. 06, 2022
  • Patent Title: Tampon press jaws Jul. 26, 2022
  • Patent Title: Method of winding up tampon material May. 18, 2021
  • Patent Title: Catamenial tampon May. 19, 2020
  • Patent Title: Tampon with penetrating groove segments Jul. 03, 2018
  • Patent Title: Tampon with penetrating groove segments Jul. 03, 2018
  • Patent Title: Surgical implant Apr. 24, 2018
  • Patent Title: Catamenial tampon Dec. 05, 2017
  • Patent Title: Method of shaping a tampon for feminine hygiene Oct. 24, 2017
  • Patent Title: Method of shaping a tampon for feminine hygiene Apr. 18, 2017
  • Patent Title: Assay device and method Mar. 28, 2017
  • Patent Title: Method for the analysis of circulating antibodies Mar. 15, 2016
  • Patent Title: Fluorescence reader Mar. 08, 2016
  • Patent Title: Tampon with penetrating groove segments Oct. 27, 2015
  • Patent Title: Assay device and method Jun. 16, 2015
  • Patent Title: Assay device and method Mar. 10, 2015
  • Patent Title: Assay device and method Nov. 04, 2014
  • Patent Title: Tampon with continuous groove forms Sep. 16, 2014
  • Patent Title: Tampon with extended groove forms Sep. 09, 2014
  • Patent Title: Assay method and device Sep. 02, 2014
  • Patent Title: Method and means for creating fluid transport Sep. 02, 2014
  • Patent Title: Assay device Jun. 24, 2014
  • Patent Title: Controlled flow assay device and method Jun. 17, 2014
  • Patent Title: Assay method utilizing capillary transport on non-porous substrates May. 13, 2014
  • Patent Title: Fluorescence reader Apr. 08, 2014
  • Patent Title: Patterned sheet products May. 07, 2013
  • Patent Title: Tampon for feminine hygiene and process and apparatus for manufacturing the same Mar. 26, 2013
  • Patent Title: Tampon for feminine hygiene and process and apparatus for manufacturing the same Jan. 15, 2013
  • Patent Title: Skin-care compositions May. 08, 2012
  • Patent Title: Absorbent personal care and/or cleansing product for cosmetic and/or dermatological applications comprising at least one absorbent sheet Oct. 04, 2011
  • Patent Title: Computer-directed assembly of a polynucleotide encoding a target polypeptide Jun. 21, 2011
  • Patent Title: Sanitary absorbent article assembly including an integrated disposal sheet May. 17, 2011
  • Patent Title: Bipolar forceps Jan. 11, 2011
  • Patent Title: Tissue repair device and fabrication thereof Jan. 04, 2011
  • Patent Title: Tampon having apertured film cover thermobonded to fibrous absorbent structure Dec. 28, 2010
  • Patent Title: Tampon for feminine hygiene and process and apparatus for manufacturing the same Nov. 16, 2010
  • Patent Title: Thin sanitary napkin having protrusions Jul. 13, 2010
  • Patent Title: Slot-coating apparatus Jul. 13, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to JNJ from public contracts

JNJ News

Recent insights relating to JNJ

CNBC Recommendations

Recent picks made for JNJ stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in JNJ

JNJ Analyst Ratings

JNJ Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
JNJ Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $JNJ stock a Buy, Sell, or Hold?

  • What is the price target for $JNJ stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

JNJ Top Shareholders
Shareholder
Shares Held
JNJ Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $JNJ stock?

  • Who owns the most shares of $JNJ stock?

  • What funds own $JNJ stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

JNJ Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view JNJ Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

  • Address New Brunswick, NJ
  • Market Cap 648.7 billion
  • Employees 140,800
  • Industrial Classification Pharmaceutical Preparations

Johnson & Johnson (JNJ) Historical Stock Prices

Johnson & Johnson (JNJ) closed at $269.19 on September 22, 2026. Over the past year its adjusted close ranged from $170.38 to $278.43. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month+0.10%
  • 3 months+13.15%
  • Year to date+32.17%
  • 1 year+57.99%
  • 3 years+82.64%
  • 5 years+87.71%
  • Max+319.33%
See every congressional and insider trade on the JNJ price chart

Quiver Premium charts JNJ's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 267.51 270.10 265.04 269.19 269.19 5,682,566
Sep 21, 2026 271.74 273.73 268.50 269.47 269.47 4,487,724
Sep 18, 2026 269.45 272.11 267.20 269.99 269.99 16,428,384
Sep 17, 2026 268.00 270.87 267.11 270.22 270.22 6,572,482
Sep 16, 2026 266.81 268.65 266.30 267.28 267.28 4,888,657
Sep 15, 2026 265.81 267.20 260.68 267.20 267.20 5,284,830
Sep 14, 2026 271.00 271.55 266.19 266.32 266.32 4,742,712
Sep 11, 2026 268.03 270.40 265.25 265.58 265.58 4,706,291
Sep 10, 2026 270.21 271.27 265.72 266.35 266.35 4,931,607
Sep 9, 2026 268.51 270.10 266.73 267.08 267.08 6,125,049
Sep 8, 2026 271.28 271.99 266.88 269.12 269.12 8,085,992
Sep 4, 2026 275.13 277.80 274.75 275.23 275.23 4,320,878
Sep 3, 2026 277.32 278.89 273.15 278.43 278.43 5,940,829
Sep 2, 2026 274.74 281.07 273.53 275.21 275.21 7,913,032
Sep 1, 2026 270.83 271.91 267.02 271.19 271.19 6,035,314
Aug 31, 2026 267.12 267.77 265.17 265.85 265.85 7,900,418
Aug 28, 2026 265.78 268.38 264.27 268.04 268.04 5,766,429
Aug 27, 2026 268.45 268.45 263.83 265.77 265.77 7,311,379
Aug 26, 2026 271.97 272.90 269.55 270.00 270.00 7,220,371
Aug 25, 2026$1.34 dividend 271.00 273.80 270.18 273.14 273.14 4,688,017
Aug 24, 2026 269.74 273.98 268.57 273.04 271.71 5,437,473
Aug 21, 2026 267.83 272.65 267.00 270.24 268.92 6,186,832
Aug 20, 2026 273.40 273.40 267.37 267.37 266.06 6,475,879
Aug 19, 2026 273.00 276.47 270.56 273.41 272.07 7,728,511
Aug 18, 2026 267.67 271.73 266.33 271.11 269.79 7,838,157
Aug 17, 2026 258.87 264.28 258.01 262.37 261.09 5,515,539
Aug 14, 2026 260.65 261.71 259.16 260.35 259.08 4,998,288
Aug 13, 2026 261.73 262.62 259.65 262.08 260.80 4,852,713
Aug 12, 2026 256.00 261.41 255.25 260.86 259.59 4,629,325
Aug 11, 2026 261.23 264.15 258.36 259.80 258.53 5,945,941
Aug 10, 2026 259.06 262.00 258.55 261.81 260.53 8,985,115
Aug 7, 2026 255.89 259.60 255.12 259.24 257.97 6,532,116
Aug 6, 2026 261.71 262.11 255.28 256.98 255.72 6,931,752
Aug 5, 2026 255.25 259.32 254.47 257.59 256.33 6,472,628
Aug 4, 2026 254.41 255.52 250.44 254.93 253.69 7,362,394
Aug 3, 2026 254.97 257.75 250.91 254.41 253.17 8,136,276
Jul 31, 2026 256.01 258.48 253.29 256.35 255.10 6,782,065
Jul 30, 2026 259.03 260.52 254.56 255.82 254.57 8,219,560
Jul 29, 2026 268.50 269.34 264.79 265.53 264.23 6,111,627
Jul 28, 2026 270.00 274.90 266.18 266.73 265.43 10,497,911
Jul 27, 2026 262.55 268.80 261.35 265.95 264.65 9,647,870
Jul 24, 2026 261.43 263.71 259.61 263.40 262.11 6,351,847
Jul 23, 2026 255.24 260.20 254.42 259.27 258.00 8,063,250
Jul 22, 2026 252.76 256.29 251.21 255.63 254.38 9,100,164
Jul 21, 2026 247.45 251.34 245.49 250.61 249.39 7,793,070
Jul 20, 2026 252.01 254.18 248.63 248.82 247.60 8,114,657
Jul 17, 2026 252.59 255.66 251.95 253.04 251.81 10,167,706
Jul 16, 2026 248.90 253.54 246.30 249.97 248.75 11,097,643
Jul 15, 2026 250.09 256.83 246.05 247.02 245.81 10,547,295
Jul 14, 2026 255.53 256.39 252.14 253.85 252.61 8,770,553
Jul 13, 2026 257.95 259.52 256.15 257.77 256.51 5,272,240
Jul 10, 2026 260.19 261.30 255.52 256.98 255.72 6,534,728
Jul 9, 2026 260.63 263.45 258.13 259.10 257.83 6,426,079
Jul 8, 2026 268.60 268.60 263.13 263.40 262.11 6,769,425
Jul 7, 2026 264.89 269.43 264.05 267.24 265.94 9,089,652
Jul 6, 2026 260.23 261.38 255.93 259.33 258.06 6,803,700
Jul 2, 2026 255.78 263.10 254.00 263.04 261.76 8,000,738
Jul 1, 2026 253.25 254.20 251.07 253.98 252.74 6,516,504
Jun 30, 2026 259.00 259.90 253.17 253.97 252.73 8,469,520
Jun 29, 2026 253.19 258.58 252.03 258.51 257.25 8,608,378
Jun 26, 2026 248.27 255.11 247.87 254.66 253.42 16,316,770
Jun 25, 2026 241.27 248.19 240.88 244.88 243.69 10,134,552
Jun 24, 2026 239.89 243.04 238.75 241.00 239.82 8,139,188
Jun 23, 2026 235.64 239.80 234.35 239.08 237.91 11,802,001
Jun 22, 2026 228.95 231.45 227.50 231.29 230.16 8,518,348
Jun 18, 2026 231.78 232.75 227.60 228.39 227.28 18,989,761
Jun 17, 2026 234.03 235.43 230.70 234.20 233.06 8,548,042
Jun 16, 2026 236.37 236.37 231.02 235.18 234.03 7,718,142
Jun 15, 2026 239.00 239.50 233.58 235.66 234.51 7,731,954
Jun 12, 2026 240.00 240.91 237.52 240.87 239.69 6,459,438
Jun 11, 2026 240.00 241.60 238.14 238.33 237.17 7,398,981
Jun 10, 2026 238.85 240.93 237.05 238.49 237.33 8,350,790
Jun 9, 2026 232.38 237.71 230.41 237.00 235.84 8,354,459
Jun 8, 2026 232.77 234.95 230.56 232.16 231.03 7,559,782
Jun 5, 2026 230.00 235.22 229.00 232.77 231.63 8,034,922
Jun 4, 2026 227.09 228.67 225.90 228.17 227.06 7,274,807
Jun 3, 2026 222.45 224.93 222.00 223.24 222.15 6,507,220
Jun 2, 2026 222.58 225.50 221.17 222.89 221.80 5,668,958
Jun 1, 2026 223.20 224.44 220.84 223.51 222.42 8,040,997
May 29, 2026 231.23 231.50 224.59 225.33 224.23 13,901,493
May 28, 2026 230.03 231.87 229.73 230.80 229.67 7,194,961
May 27, 2026 229.98 232.89 229.02 231.29 230.16 5,836,343
May 26, 2026$1.34 dividend 233.00 233.24 229.08 230.18 229.06 6,623,641
May 22, 2026 233.00 235.50 232.72 234.34 231.85 5,464,729
May 21, 2026 229.31 231.89 227.35 231.73 229.26 5,239,027
May 20, 2026 231.69 232.00 229.17 229.32 226.88 7,353,781
May 19, 2026 228.94 230.85 228.04 230.00 227.55 9,677,943
May 18, 2026 226.71 229.70 225.86 228.92 226.48 10,141,610
May 15, 2026 230.77 232.13 226.44 226.71 224.30 12,166,950
May 14, 2026 231.00 231.76 229.16 230.80 228.34 6,974,439
May 13, 2026 225.82 230.80 225.44 230.42 227.97 7,464,490
May 12, 2026 223.00 227.65 221.65 224.26 221.87 8,632,470
May 11, 2026 221.32 223.28 220.37 221.43 219.07 6,223,182
May 8, 2026 222.94 223.37 220.92 221.32 218.97 5,550,555
May 7, 2026 224.78 224.78 220.63 222.51 220.14 7,269,708
May 6, 2026 225.25 226.34 222.95 224.62 222.23 7,982,250
May 5, 2026 225.39 226.53 224.90 225.55 223.15 5,556,720
May 4, 2026 225.51 227.07 223.58 224.20 221.81 8,215,235
May 1, 2026 229.06 229.77 227.02 227.19 224.77 6,863,587
Apr 30, 2026 227.95 231.16 227.81 229.85 227.40 8,157,165
Apr 29, 2026 225.52 228.71 224.86 227.35 224.93 7,071,144
Apr 28, 2026 227.73 231.03 226.37 227.79 225.37 7,179,849
Apr 27, 2026 225.77 227.91 224.35 225.34 222.94 7,897,807
Apr 24, 2026 229.03 229.99 227.02 227.50 225.08 6,067,521
Apr 23, 2026 227.25 231.39 227.03 230.65 228.20 7,097,642
Apr 22, 2026 226.18 227.48 223.78 226.10 223.69 9,003,352
Apr 21, 2026 229.35 229.69 224.70 226.16 223.75 11,681,243
Apr 20, 2026 234.81 235.26 229.53 230.69 228.24 7,810,471
Apr 17, 2026 234.36 235.54 232.04 234.18 231.69 8,946,288
Apr 16, 2026 237.42 238.14 232.12 234.54 232.04 8,668,883
Apr 15, 2026 239.94 240.42 236.75 238.67 236.13 6,463,456
Apr 14, 2026 235.01 242.19 233.25 240.10 237.54 10,318,725
Apr 13, 2026 237.71 238.39 235.18 237.96 235.43 7,663,571
Apr 10, 2026 242.00 242.26 237.91 238.46 235.92 7,354,528
Apr 9, 2026 241.30 244.20 240.54 241.31 238.74 6,216,497
Apr 8, 2026 236.64 241.33 233.90 241.30 238.73 8,771,117
Apr 7, 2026 240.78 240.78 236.01 238.41 235.87 6,241,146
Apr 6, 2026 242.65 243.52 240.50 240.97 238.41 4,442,427
Apr 2, 2026 245.11 247.21 241.87 243.04 240.45 6,878,704
Apr 1, 2026 245.60 247.20 243.74 244.12 241.52 6,314,634
Mar 31, 2026 243.01 245.33 242.65 244.44 241.84 7,554,152
Mar 30, 2026 243.49 244.21 240.51 242.49 239.91 7,241,324
Mar 27, 2026 241.19 242.68 239.13 240.45 237.89 7,617,616
Mar 26, 2026 240.00 241.65 238.93 239.24 236.69 5,171,440
Mar 25, 2026 236.80 241.46 235.73 239.93 237.38 6,456,736
Mar 24, 2026 234.14 236.00 232.24 235.27 232.77 9,046,201
Mar 23, 2026 237.40 238.31 234.25 235.42 232.91 7,313,653
Mar 20, 2026 236.83 238.29 234.50 235.37 232.87 17,156,623
Mar 19, 2026 238.34 239.26 236.31 237.60 235.07 7,511,537
Mar 18, 2026 237.87 239.11 235.42 237.28 234.75 6,811,546
Mar 17, 2026 243.58 244.14 237.22 238.11 235.58 7,281,819
Mar 16, 2026 243.92 245.06 241.67 243.19 240.60 7,571,757
Mar 13, 2026 244.21 245.59 241.50 241.52 238.95 6,415,539
Mar 12, 2026 241.46 244.40 240.30 242.04 239.46 7,710,152
Mar 11, 2026 242.87 243.69 241.36 242.99 240.40 6,934,842
Mar 10, 2026 242.30 245.00 240.82 243.71 241.12 7,214,122
Mar 9, 2026 240.87 244.09 240.04 242.59 240.01 7,844,028
Mar 6, 2026 238.12 240.79 235.43 240.40 237.84 7,179,790
Mar 5, 2026 242.63 243.00 235.93 239.63 237.08 9,375,413
Mar 4, 2026 245.75 246.57 243.18 245.30 242.69 5,767,980
Mar 3, 2026 246.46 247.88 244.36 246.75 244.12 6,178,739
Mar 2, 2026 249.19 251.71 246.87 248.56 245.91 9,042,359
Feb 27, 2026 244.03 248.94 242.50 248.43 245.79 16,428,550
Feb 26, 2026 245.11 245.47 242.02 243.47 240.88 7,172,607
Feb 25, 2026 244.86 247.25 243.72 245.17 242.56 7,698,199
Feb 24, 2026$1.3 dividend 245.34 247.25 244.54 246.28 243.66 7,246,280
Feb 23, 2026 243.63 246.81 242.60 245.84 241.95 9,622,742
Feb 20, 2026 246.47 246.88 240.28 242.49 238.65 13,565,791
Feb 19, 2026 244.62 246.96 244.27 246.91 243.00 7,553,934
Feb 18, 2026 243.24 245.06 242.82 244.99 241.11 8,129,663
Feb 17, 2026 244.13 244.49 241.87 243.33 239.48 12,703,029
Feb 13, 2026 244.59 244.95 242.61 243.45 239.59 13,268,519
Feb 12, 2026 240.48 246.35 239.68 244.55 240.68 10,254,260
Feb 11, 2026 239.34 241.26 237.40 240.86 237.05 6,803,917
Feb 10, 2026 239.98 240.50 237.88 238.35 234.57 6,723,253
Feb 9, 2026 240.25 240.74 237.04 238.64 234.86 9,378,548
Feb 6, 2026 238.96 240.94 237.98 239.99 236.19 8,274,034
Feb 5, 2026 235.00 239.58 234.99 237.79 234.02 10,267,498
Feb 4, 2026 235.00 235.83 232.94 234.47 230.76 8,641,449
Feb 3, 2026 231.50 235.20 230.48 233.10 229.41 9,346,605
Feb 2, 2026 228.32 231.19 227.25 230.75 227.10 8,187,529
Jan 30, 2026 228.26 228.50 225.33 227.25 223.65 11,045,529
Jan 29, 2026 228.81 230.00 227.08 227.29 223.69 9,645,348
Jan 28, 2026 226.40 228.57 226.07 227.72 224.11 9,026,495
Jan 27, 2026 222.00 225.50 220.70 224.44 220.89 8,154,489
Jan 26, 2026 220.21 222.03 220.00 221.49 217.98 6,857,093
Jan 23, 2026 219.80 221.21 217.84 220.14 216.65 6,951,040
Jan 22, 2026 218.77 222.17 218.10 218.49 215.03 13,160,041
Jan 21, 2026 211.00 218.68 210.50 218.01 214.56 14,762,883
Jan 20, 2026 217.09 218.72 214.50 218.21 214.75 14,057,136
Jan 16, 2026 219.04 220.11 218.13 218.66 215.20 10,021,515
Jan 15, 2026 218.23 219.75 215.91 219.57 216.09 8,492,116
Jan 14, 2026 214.73 218.86 214.15 218.55 215.09 11,858,784
Jan 13, 2026 209.91 214.39 208.86 213.65 210.27 11,379,590
Jan 12, 2026 205.55 209.90 203.85 209.72 206.40 11,794,339
Jan 9, 2026 205.91 206.70 204.01 204.39 201.15 6,154,326
Jan 8, 2026 206.93 208.98 204.97 205.75 202.49 6,557,776
Jan 7, 2026 205.26 208.26 205.03 207.49 204.20 7,545,920
Jan 6, 2026 204.60 206.71 204.12 204.79 201.55 8,107,853
Jan 5, 2026 205.87 205.94 200.91 204.31 201.07 9,476,975
Jan 2, 2026 206.82 207.38 203.68 207.35 204.07 6,325,672
Dec 31, 2025 206.91 207.50 206.37 206.95 203.67 4,084,013
Dec 30, 2025 207.51 207.69 206.52 206.91 203.63 3,937,395
Dec 29, 2025 208.00 209.47 207.38 207.56 204.27 4,348,854
Dec 26, 2025 207.53 208.04 206.71 207.63 204.34 2,316,730
Dec 24, 2025 206.00 207.94 205.57 207.78 204.49 2,376,541
Dec 23, 2025 205.02 206.53 203.28 205.78 202.52 7,047,346
Dec 22, 2025 206.13 208.08 205.50 207.32 204.04 8,187,755
Dec 19, 2025 207.56 209.24 206.03 206.37 203.10 24,803,920
Dec 18, 2025 209.80 211.06 207.76 208.31 205.01 7,499,852
Dec 17, 2025 209.38 211.51 208.46 210.33 207.00 8,457,560
Dec 16, 2025 214.00 214.73 208.81 209.30 205.99 9,949,810
Dec 15, 2025 210.34 215.19 209.01 214.17 210.78 8,466,964
Dec 12, 2025 210.28 212.27 208.96 211.58 208.23 6,922,683
Dec 11, 2025 207.90 211.24 207.83 210.01 206.68 9,008,960
Dec 10, 2025 200.59 206.80 200.18 206.54 203.27 11,599,785
Dec 9, 2025 202.92 205.54 199.91 199.96 196.79 7,509,402
Dec 8, 2025 202.66 203.25 200.99 201.62 198.43 7,785,708
Dec 5, 2025 202.98 203.45 200.81 201.93 198.73 7,785,552
Dec 4, 2025 204.59 204.86 201.71 202.48 199.27 9,049,943
Dec 3, 2025 205.90 207.02 204.99 205.33 202.08 8,363,292
Dec 2, 2025 205.24 205.61 203.10 205.42 202.17 8,393,565
Dec 1, 2025 206.50 207.70 205.34 205.34 202.09 8,473,726
Nov 28, 2025 207.00 207.46 204.63 206.92 203.64 5,638,279
Nov 26, 2025 206.49 207.81 205.94 207.56 204.27 6,728,994
Nov 25, 2025$1.3 dividend 205.18 207.72 205.18 206.67 203.40 10,275,724
Nov 24, 2025 203.71 206.12 203.00 206.05 201.52 14,803,873
Nov 21, 2025 203.96 206.94 202.99 203.90 199.42 13,189,055
Nov 20, 2025 202.00 204.51 201.57 203.07 198.60 10,612,550
Nov 19, 2025 200.00 203.48 199.38 202.51 198.06 14,690,837
Nov 18, 2025 199.01 200.30 198.53 200.00 195.60 12,468,619
Nov 17, 2025 196.96 200.28 195.90 199.58 195.19 13,256,995
Nov 14, 2025 195.00 197.18 193.55 195.93 191.62 8,824,847
Nov 13, 2025 194.21 196.00 193.45 195.25 190.96 8,631,614
Nov 12, 2025 193.36 195.54 193.07 194.39 190.12 8,803,005
Nov 11, 2025 189.38 193.92 189.05 193.83 189.57 7,465,592
Nov 10, 2025 186.00 188.42 185.12 188.41 184.27 5,324,077
Nov 7, 2025 187.74 188.35 185.70 186.57 182.47 6,959,209
Nov 6, 2025 186.76 187.52 185.37 186.97 182.86 6,767,417
Nov 5, 2025 186.64 187.83 185.40 186.00 181.91 5,049,443
Nov 4, 2025 186.83 187.82 185.62 186.86 182.75 7,209,395
Nov 3, 2025 189.00 189.03 185.52 186.26 182.16 7,542,636
Oct 31, 2025 187.46 189.50 186.76 188.87 184.72 8,791,666
Oct 30, 2025 187.08 189.38 186.91 189.05 184.89 7,072,517
Oct 29, 2025 186.70 187.10 184.66 186.60 182.50 10,551,079
Oct 28, 2025 189.26 189.50 186.62 186.93 182.82 8,329,457
Oct 27, 2025 189.99 190.80 189.53 190.30 186.12 7,125,956
Oct 24, 2025 192.20 192.31 189.42 190.40 186.21 6,903,379
Oct 23, 2025 192.56 194.00 191.54 192.47 188.24 8,882,491
Oct 22, 2025 192.00 193.45 191.78 192.94 188.70 6,343,472
Oct 21, 2025 193.01 193.55 191.77 191.88 187.66 6,716,360
Oct 20, 2025 193.50 194.48 192.33 193.72 189.46 8,034,740
Oct 17, 2025 192.50 193.60 191.68 193.22 188.97 7,764,449
Oct 16, 2025 191.34 193.05 190.43 192.12 187.90 10,611,760
Oct 15, 2025 191.48 193.57 189.30 191.17 186.97 9,472,995
Oct 14, 2025 192.92 194.40 185.88 190.85 186.65 13,613,340
Oct 13, 2025 189.83 191.30 189.28 190.90 186.70 7,979,476
Oct 10, 2025 192.01 192.07 189.85 190.72 186.53 9,598,019
Oct 9, 2025 190.00 192.10 189.73 191.08 186.88 7,484,764
Oct 8, 2025 188.87 190.22 188.27 189.69 185.52 5,751,163
Oct 7, 2025 183.77 189.23 182.94 188.89 184.74 8,776,784
Oct 6, 2025 188.00 189.92 187.37 188.16 184.02 5,806,089
Oct 3, 2025 187.06 189.78 186.91 188.64 184.49 8,675,087
Oct 2, 2025 184.19 186.59 184.09 185.98 181.89 7,728,069
Oct 1, 2025 186.00 186.56 183.91 186.05 181.96 13,063,788
Sep 30, 2025 181.70 185.99 181.07 185.42 181.34 11,569,019
Sep 29, 2025 179.82 181.87 179.80 181.62 177.63 8,597,085
Sep 26, 2025 178.60 179.91 177.32 179.71 175.76 8,662,641
Sep 25, 2025 177.20 178.40 175.91 177.73 173.82 8,474,977
Sep 24, 2025 176.14 176.95 175.74 176.69 172.81 6,676,772
Sep 23, 2025 174.89 176.97 174.83 176.58 172.70 8,350,745
Sep 22, 2025 176.09 176.64 174.12 174.21 170.38 7,194,036

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Johnson & Johnson Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at JNJ, per a recent SEC DEF 14A filing. We estimate that the median employee at JOHNSON & JOHNSON is paid $83,000.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation